Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of the JAK2V617F mutation in patients with slightly elevated platelets or hemoglobin without a secondary cause.

Annals of hematology - 1 Nov 2007

Strobbe Leonie, Lestrade Peter, Hermans Mirjam H A, Fijnheer Rob

Abstract excerpt

Recently, an activating somatic mutation of Janus kinase 2 (JAK2V617F) was identified in the myeloproliferative disorders (MPDs). In this study, we investigated the occurrence of JAK2V617F in patients with slightly elevated platelets or hemoglobin without a secondary cause, who did not meet the criteria of polycythemia vera or essential thrombocythemia. Six out of 18 patients (33%) were positive for the JAK2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemoglobins

Share to Janus Kinase 2

Share to Myeloproliferative Disorders

Share to Polycythemia

Share to Thrombocytosis

Share to Thrombosis

Source

Identifiers

PMID: 17703302
DOI: 10.1007/s00277-007-0355-x

Genes

JAK2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detection of the JAK2V617F mutation in patients with slightly elevated platelets or hemoglobin without a secondary cause.PMID 17703302Read ↗

Thrombocytosis and thrombosis.Semantic proximity Read ↗

JAK2-V617F mutation analysis of granulocytes and platelets from patients with chronic myeloproliferative disorders: advantage of studying platelets.Semantic proximity Read ↗

Correlative study between the JAK2V617F mutation and thrombosis in patients with myeloproliferative neoplasm.Semantic proximity Read ↗

The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis.Semantic proximity Read ↗

The JAK2(V617F) tyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis.Semantic proximity Read ↗

Low prevalence of JAK2 V617F mutation in patients with thrombosis and normal blood counts: a retrospective impact study.Semantic proximity Read ↗

JAK2 mutation and thrombosis in the myeloproliferative neoplasms.Semantic proximity Read ↗

Association of JAK2V617F mutation with thrombosis in Indian patients with Philadelphia negative chronic myeloproliferative neoplasms.Semantic proximity Read ↗

Prevalence of definite antiphospholipid syndrome in carriers of the JAK2V617F mutation.Semantic proximity Read ↗

Association between thromboembolic events and the JAK2 V617F mutation in myeloproliferative neoplasms.Semantic proximity Read ↗

[Correlative study between JAK2 mutation and thrombosis in patients with myeloproliferative neoplasm].Semantic proximity Read ↗

Prevalence of Janus Kinase 2 mutations in patients with unusual site venous thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.